Conoscere EBM
- Definizione
- Acronimi
- Cronologia
- Ambiti
- Know-how e strumenti
- EBM in 4 step
- Limiti e ostacoli

EB Practice
- Formulazione quesito
- Ricerca evidenze
- Valutazione evidenze
- Applicazione evidenze

EBHC Library
- Risorse in italiano

SSN Hot Topics
- Appropriatezza
- Conflitti di interesse
- ECM
- Farmaci
- Governo Clinico
- LEA

InfoSanità

GIMBE^®

Workshop
Evidence based Medicine
Le opportunità per un linguaggio comune
Terza edizione

Como, 1-2 aprile 2006

8 crediti ECM

in collaborazione con

Società
Nazionale di
Aggiornamento
Medico
InterDisciplinare

Sezione di Como

Gli articoli non disponibili in full text possono essere richiesti a: info@gimbe.org

Introduzione

• Slides

Workshop Clinico Interattivo 1. La gestione integrata del paziente con scompenso cardiaco: molte evidenze, scarsa integrazione tra i servizi
Conduttore: Antonino Cartabellotta.
Discussant: Danila Briganti, Mauro Santarone

• Slides

• Evidence appraised

  • Linee guida "Scompenso cardiaco"
    • European Society of Cardiology
      • Guidelines for the Diagnosis and Treatment of Chronic Heart Failure. Eur Heart J 2001;22:1527-1560
    • Prodigy
      • Heart Failure, 2004
    • National Institute for Clinical Excellence (NICE) and Royal College of Physicians (RCP)
      • Chronic heart failure: management of chronic heart failure in adults in primary and secondary care. July 2003
        • Full guideline
        • Quick guideline
    • American College of Cardiology/American Heart Association (ACC/AHA)
      • ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. August, 2005
    • National Heart Foundation of New Zealand
      • A Guideline for the Management of Heart Failure: health professionals guide. December 2001
  • Liee guida "Fibrillazione atriale"
    • New Zealand Guidelines Group (NZGG).
      • The management of people with atrial fibrillation and flutter. May, 2005
    • Snow V, et al. Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 2003;139:1009-17
    • McNamara RL, et al. Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann Intern Med 2003;139:1018-33
  • Evidence summaries
    • Heart Failure. Clinical Evidence, March 2004 (Last search, October 2002)
  • Revisioni sistematiche
  • Cochrane
    • Taylor S, Bestall J, Cotter S, Falshaw M, Hood S, Parsons S, Wood L, Underwood M. Clinical service organisation for heart failure. The Cochrane Database of Systematic Reviews 2005, Issue 2.
    • Mead GE, Elder AT, Flapan AD, Kelman A.Electrical cardioversion for atrial fibrillation and flutter.The Cochrane Database of Systematic Reviews 2006 Issue 1
    • Cordina J, Mead G. Pharmacological cardioversion for atrial fibrillation and flutter.The Cochrane Database of Systematic Reviews 2006 Issue 1
  • Non-Cochrane
    • de Denus S, Sanoski C A, Carlsson J, et al. Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis. Arch  Intern Med 2005;165:258-262.
      • Record DARE
    • Dulin B R, Haas S J, Abraham W T, Krum H. Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly: meta-analysis of >12,000 patients in large-scale clinical trials. Am J Cardiol 2005;95:896-898
      • Record DARE
    • Phillips CO, et al. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. JAMA 2004;291:1358-67
    • McAlister FA, et al. A systematic review of randomized trials of disease management programs in heart failure  Am J Med 2001;110(5):378-384. [abstract]
      • Record DARE

Tavola rotonda. Hot topic. Le medicine non convenzionali: tra prove di efficacia, rischi e stregoneria
Conduce: Antonino Cartabellotta.
Partecipano:

• Slides

La diagnostica del paziente allergico: troppi test a tutti i pazienti?
Conduttore: Antonino Cartabellotta.
Discussant: Carmen Sampietro, Marina Russello

• Slides

• Evidence appraised

  • Linee guida

    • Corbillon E, Rame J-M. Indications for the specific-IgE test for the diagnosis and monitoring of allergies. Saint-Denis La Plaine: Haute Autorite de Sante/French National Authority for Health (HAS), 2005:145
      • Record DARE
    • Blue Cross Blue Shield Association. Serial endpoint testing for the diagnosis and treatment of allergic disorders. Chicago IL: Blue Cross Blue Shield Association (BCBS), 2002:19.
      • Record DARE
    • American Gastroenterological Association medical position statement: guidelines for the evaluation of food allergies. Gastroenterology 2001;120:1023-5
    • Royal College of Physicians (UK)
      • Allergy: the unmet need, 2004
    • Royal College of Pathologists (UK)
      • Allergy and allergy tests: A guide for patients and relatives, 2005

  • Revisioni non sistematiche

    • Li JT. Allergy testing. Am Fam Physician 2002;66:621-4.

Workshop Metodologico. L’effetto classe: quando due farmaci sono realmente simili?

Conduttore: Antonino Cartabellotta

• Slides

FANS, coxib e oppiacei: il trattamento del dolore tra prove di efficacia ed effetti collaterali
Conduttore: Antonino Cartabellotta.
Discussant: Daniele Luraschi, Maurizio Ferretta

• Slides

La valutazione del rischio tromboembolico tra credenze ed evidenze: quale ruolo per il MMG?
Conduttore: Antonino Cartabellotta.
Discussant: Maurizio Mancuso, Angelo Beretta

• Slides

• Evidence appraised

• Evidence summaries
  • Gøtzsche PC. Non-steroidal anti-inflammatory drugs. December 2004
• Revisioni sistematiche
• Cochrane
  • Clarke M, Fischer M, Hopewell S, Juszczak E, Eisinga A.Compression stockings for preventing deep vein thrombosis in airline passengers. The Cochrane Database of Systematic Reviews 2006 Issue 1  [protocol]
  • Schraibman IG, Milne AA, Royle EM. Home versus in-patient treatment for deep vein thrombosis. The Cochrane Database of Systematic Reviews 2001, Issue 2.
  • Hutten BA, Prins MH. Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism.The Cochrane Database of Systematic Reviews 2006 Issue 1
  • van der Heijden JF, Hutten BA, Büller HR, Prins MH.Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.The Cochrane Database of Systematic Reviews 2006 Issue 1
• Non-Cochrane
  • Adi Y, Bayliss S, Rouse A, Taylor RS. The association between air travel and deep vein thrombosis: systematic review & meta-analysis. BMC Cardiovasc Disord. 2004 May 19;4:7.
  • Goodacre S, Sutton A J, Sampson F C. Meta-analysis: the value of clinical assessment in the diagnosis of deep venous thrombosis. Ann Intern Med 2005;143:129-139.
  • Wu O, Robertson L, Twaddle S, et al. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Related Articles, Links Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. Br J Haematol. 2005 Oct;131(1):80-90.
  • Wu O, Robertson L, Twaddle S, Lowe G, Clark P, Walker I, Brenkel I, Greaves M, Langhorne P, Regan L, Greer I; The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Related Articles, Links Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. Br J Haematol. 2005 Oct;131(1):80-90.
  • Fancher T L, White R H, Kravitz R L. Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review. BMJ, 2004;329:821.
  • Kemmeren JM, Algra A, Grobbee DE. Related Articles, Links Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ. 2001 Jul 21;323(7305):131-4.